BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazagova M, Buikema H, Landheer SW, Vavrinec P, Buiten AV, Henning RH, Deelman LE. Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium. American Journal of Physiology-Heart and Circulatory Physiology 2013;304:H709-18. [DOI: 10.1152/ajpheart.00543.2012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Tandara L, Filipi P, Supe Domic D, Kresic B, Ivcic I, Stojanovic Stipic S, Rubic Z, Tandara M. Laboratory medicine in pandemic of COVID-19. Biochemia Medica 2022;32:020501. [DOI: 10.11613/bm.2022.020501] [Reference Citation Analysis]
2 Willy K, Girndt M, Voelkl J, Fiedler R, Martus P, Storr M, Schindler R, Zickler D. Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro. Blood Purif 2018;45:131-8. [PMID: 29402827 DOI: 10.1159/000484925] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
3 Muniyan S, Pothuraju R, Seshacharyulu P, Batra SK. Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215664] [Reference Citation Analysis]
4 Andersson C, Preis SR, Beiser A, DeCarli C, Wollert KC, Wang TJ, Januzzi JL Jr, Vasan RS, Seshadri S. Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke. Stroke 2015;46:2568-75. [PMID: 26219649 DOI: 10.1161/STROKEAHA.115.009026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
5 Unsicker K, Spittau B, Krieglstein K. The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1. Cytokine & Growth Factor Reviews 2013;24:373-84. [DOI: 10.1016/j.cytogfr.2013.05.003] [Cited by in Crossref: 149] [Cited by in F6Publishing: 151] [Article Influence: 16.6] [Reference Citation Analysis]
6 Muralidharan AR, Maddala R, Skiba NP, Rao PV. Growth Differentiation Factor-15-Induced Contractile Activity and Extracellular Matrix Production in Human Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci 2016;57:6482-95. [PMID: 27918822 DOI: 10.1167/iovs.16-20671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mestres-Arenas A, Villarroya J, Giralt M, Villarroya F, Peyrou M. A Differential Pattern of Batokine Expression in Perivascular Adipose Tissue Depots From Mice. Front Physiol 2021;12:714530. [PMID: 34421656 DOI: 10.3389/fphys.2021.714530] [Reference Citation Analysis]
8 Hong T, Xiao X, Ren J, Cui B, Zong Y, Zou J, Kou Z, Jiang N, Meng G, Zeng G, Shan Y, Wu H, Chen Z, Liang J, Xiao X, Tang J, Wei Y, Ye M, Sun L, Li G, Hu P, Hui R, Zhang H, Wang Y. Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain 2021:awab117. [PMID: 33729480 DOI: 10.1093/brain/awab117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rochette L, Zeller M, Cottin Y, Vergely C. Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets. Trends Endocrinol Metab 2020;31:939-51. [PMID: 33172749 DOI: 10.1016/j.tem.2020.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Rochette L, Dogon G, Zeller M, Cottin Y, Vergely C. GDF15 and Cardiac Cells: Current Concepts and New Insights. Int J Mol Sci 2021;22:8889. [PMID: 34445593 DOI: 10.3390/ijms22168889] [Reference Citation Analysis]
11 Niu Y, Zhang W, Shi J, Liu Y, Zhang H, Lin N, Li X, Qin L, Yang Z, Su Q. The Relationship Between Circulating Growth Differentiation Factor 15 Levels and Diabetic Retinopathy in Patients With Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:627395. [PMID: 33790859 DOI: 10.3389/fendo.2021.627395] [Reference Citation Analysis]
12 Takenouchi Y, Kitakaze K, Tsuboi K, Okamoto Y. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts. Exp Cell Res 2020;391:112010. [PMID: 32305327 DOI: 10.1016/j.yexcr.2020.112010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Mazagova M, Buikema H, van Buiten A, Duin M, Goris M, Sandovici M, Henning RH, Deelman LE. Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes. Am J Physiol Renal Physiol 2013;305:F1249-64. [PMID: 23986522 DOI: 10.1152/ajprenal.00387.2013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
14 Rochette L, Zeller M, Cottin Y, Vergely C. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism. Trends Endocrinol Metab 2021;32:875-89. [PMID: 34593305 DOI: 10.1016/j.tem.2021.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kastritis E, Papassotiriou I, Merlini G, Milani P, Terpos E, Basset M, Akalestos A, Russo F, Psimenou E, Apostolakou F, Roussou M, Gavriatopoulou M, Eleutherakis-papaiakovou E, Fotiou D, Ziogas DC, Papadopoulou E, Pamboucas C, Dimopoulos MA, Palladini G. Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis. Blood 2018;131:1568-75. [DOI: 10.1182/blood-2017-12-819904] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
16 Senadheera S, Bertrand PP, Grayson TH, Leader L, Murphy TV, Sandow SL. Pregnancy-induced remodelling and enhanced endothelium-derived hyperpolarization-type vasodilator activity in rat uterine radial artery: transient receptor potential vanilloid type 4 channels, caveolae and myoendothelial gap junctions. J Anat 2013;223:677-86. [PMID: 24128141 DOI: 10.1111/joa.12127] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
17 Wesseling M, de Poel JHC, de Jager SCA. Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player. ESC Heart Fail 2020;7:1488-501. [PMID: 32424982 DOI: 10.1002/ehf2.12728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Cruickshank T, MacDonald TM, Walker SP, Keenan E, Dane K, Middleton A, Kyritsis V, Myers J, Cluver C, Hastie R, Bergman L, Garcha D, Cannon P, Murray E, Nguyen TV, Hiscock R, Pritchard N, Hannan NJ, Tong S, Kaitu'u-Lino TJ. Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis: Implications as a Disease Biomarker. J Am Heart Assoc 2021;10:e020302. [PMID: 34387117 DOI: 10.1161/JAHA.120.020302] [Reference Citation Analysis]
19 Teunissen CE, Durieux-Lu S, Blankenstein MA, Oude Voshaar RC, Comijs HC. The inflammatory marker GDF-15 is not independently associated with late-life depression. J Psychosom Res 2016;83:46-9. [PMID: 27020076 DOI: 10.1016/j.jpsychores.2016.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Evans BR, Yerly A, van der Vorst EPC, Baumgartner I, Bernhard SM, Schindewolf M, Döring Y. Inflammatory Mediators in Atherosclerotic Vascular Remodeling. Front Cardiovasc Med 2022;9:868934. [DOI: 10.3389/fcvm.2022.868934] [Reference Citation Analysis]